vs
indie Semiconductor, Inc.（INDI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
indie Semiconductor, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.6倍（$58.0M vs $35.5M），indie Semiconductor, Inc.净利率更高（-53.8% vs -304.2%，领先250.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -0.0%），indie Semiconductor, Inc.自由现金流更多（$-16.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 5.3%）
indie Semiconductor是一家无晶圆厂半导体企业，专注于设计高性能混合信号及嵌入式片上系统解决方案，核心面向汽车领域，产品覆盖高级驾驶辅助、车载信息娱乐、车联网及电动汽车场景，服务全球汽车整车厂商及一级供应商。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
INDI vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.0M | $35.5M |
| 净利润 | $-31.2M | $-108.1M |
| 毛利率 | 37.3% | 59.8% |
| 营业利润率 | -58.5% | -304.8% |
| 净利率 | -53.8% | -304.2% |
| 营收同比 | -0.0% | 681.7% |
| 净利润同比 | 9.1% | 39.6% |
| 每股收益（稀释后） | $-0.16 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $58.0M | $35.5M | ||
| Q3 25 | $53.7M | $5.2M | ||
| Q2 25 | $51.6M | $19.2M | ||
| Q1 25 | $54.1M | $14.7M | ||
| Q4 24 | $58.0M | $4.5M | ||
| Q3 24 | $54.0M | $26.1M | ||
| Q2 24 | $52.4M | $14.4M | ||
| Q1 24 | $52.4M | $13.8M |
| Q4 25 | $-31.2M | $-108.1M | ||
| Q3 25 | $-38.3M | $-162.3M | ||
| Q2 25 | $-39.0M | $-171.9M | ||
| Q1 25 | $-34.5M | $-202.5M | ||
| Q4 24 | $-34.4M | $-178.9M | ||
| Q3 24 | $-49.7M | $-95.8M | ||
| Q2 24 | $-19.2M | $-97.5M | ||
| Q1 24 | $-31.2M | $-91.4M |
| Q4 25 | 37.3% | 59.8% | ||
| Q3 25 | 40.1% | -183.8% | ||
| Q2 25 | 40.6% | -4.9% | ||
| Q1 25 | 41.7% | -48.0% | ||
| Q4 24 | 42.6% | -181.4% | ||
| Q3 24 | 39.3% | 53.7% | ||
| Q2 24 | 42.2% | 36.2% | ||
| Q1 24 | 42.5% | 19.1% |
| Q4 25 | -58.5% | -304.8% | ||
| Q3 25 | -71.4% | -3327.6% | ||
| Q2 25 | -83.3% | -916.8% | ||
| Q1 25 | -72.0% | -1297.9% | ||
| Q4 24 | -58.4% | -4042.4% | ||
| Q3 24 | -92.5% | -377.1% | ||
| Q2 24 | -70.0% | -697.4% | ||
| Q1 24 | -94.8% | -698.4% |
| Q4 25 | -53.8% | -304.2% | ||
| Q3 25 | -71.3% | -3135.3% | ||
| Q2 25 | -75.6% | -894.2% | ||
| Q1 25 | -63.9% | -1373.3% | ||
| Q4 24 | -59.2% | -3935.5% | ||
| Q3 24 | -92.1% | -367.5% | ||
| Q2 24 | -36.6% | -676.6% | ||
| Q1 24 | -59.6% | -662.4% |
| Q4 25 | $-0.16 | $-0.17 | ||
| Q3 25 | $-0.19 | $-0.36 | ||
| Q2 25 | $-0.20 | $-0.41 | ||
| Q1 25 | $-0.18 | $-0.50 | ||
| Q4 24 | $-0.18 | $-0.56 | ||
| Q3 24 | $-0.28 | $-0.34 | ||
| Q2 24 | $-0.11 | $-0.40 | ||
| Q1 24 | $-0.19 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.5M | $743.3M |
| 总债务越低越好 | $353.4M | $9.6M |
| 股东权益账面价值 | $358.0M | $1.1B |
| 总资产 | $840.8M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.99× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $145.5M | $743.3M | ||
| Q3 25 | $160.9M | $659.8M | ||
| Q2 25 | $192.6M | $525.1M | ||
| Q1 25 | $236.6M | $500.5M | ||
| Q4 24 | $274.2M | $594.4M | ||
| Q3 24 | $96.9M | $427.6M | ||
| Q2 24 | $112.3M | $474.3M | ||
| Q1 24 | $138.2M | $296.3M |
| Q4 25 | $353.4M | $9.6M | ||
| Q3 25 | $353.5M | $11.9M | ||
| Q2 25 | $352.5M | $14.2M | ||
| Q1 25 | $379.0M | $16.4M | ||
| Q4 24 | $381.3M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $358.0M | $1.1B | ||
| Q3 25 | $369.2M | $1.0B | ||
| Q2 25 | $390.4M | $919.1M | ||
| Q1 25 | $405.6M | $933.9M | ||
| Q4 24 | $417.9M | $1.0B | ||
| Q3 24 | $458.6M | $524.6M | ||
| Q2 24 | $470.7M | $584.4M | ||
| Q1 24 | $432.9M | $401.2M |
| Q4 25 | $840.8M | $1.5B | ||
| Q3 25 | $855.1M | $1.4B | ||
| Q2 25 | $867.6M | $1.3B | ||
| Q1 25 | $909.0M | $1.3B | ||
| Q4 24 | $941.4M | $1.4B | ||
| Q3 24 | $797.5M | $726.5M | ||
| Q2 24 | $797.3M | $775.9M | ||
| Q1 24 | $803.6M | $557.8M |
| Q4 25 | 0.99× | 0.01× | ||
| Q3 25 | 0.96× | 0.01× | ||
| Q2 25 | 0.90× | 0.02× | ||
| Q1 25 | 0.93× | 0.02× | ||
| Q4 24 | 0.91× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-16.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | -27.8% | -133.1% |
| 资本支出强度资本支出/营收 | 3.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-71.4M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-14.4M | $-46.1M | ||
| Q3 25 | $-6.2M | $-117.4M | ||
| Q2 25 | $-7.6M | $-76.4M | ||
| Q1 25 | $-29.0M | $-132.0M | ||
| Q4 24 | $-6.7M | $-115.4M | ||
| Q3 24 | $-22.8M | $-59.2M | ||
| Q2 24 | $-19.7M | $-82.2M | ||
| Q1 24 | $-9.3M | $-102.3M |
| Q4 25 | $-16.1M | $-47.3M | ||
| Q3 25 | $-10.3M | $-117.6M | ||
| Q2 25 | $-13.6M | $-79.6M | ||
| Q1 25 | $-31.4M | $-133.8M | ||
| Q4 24 | $-8.6M | $-116.7M | ||
| Q3 24 | $-29.3M | $-63.8M | ||
| Q2 24 | $-23.4M | $-83.4M | ||
| Q1 24 | $-11.7M | $-109.0M |
| Q4 25 | -27.8% | -133.1% | ||
| Q3 25 | -19.2% | -2272.5% | ||
| Q2 25 | -26.4% | -413.9% | ||
| Q1 25 | -58.0% | -907.4% | ||
| Q4 24 | -14.8% | -2567.7% | ||
| Q3 24 | -54.3% | -244.6% | ||
| Q2 24 | -44.7% | -578.5% | ||
| Q1 24 | -22.3% | -789.9% |
| Q4 25 | 3.0% | 3.5% | ||
| Q3 25 | 7.8% | 4.7% | ||
| Q2 25 | 11.6% | 16.4% | ||
| Q1 25 | 4.4% | 12.4% | ||
| Q4 24 | 3.2% | 28.6% | ||
| Q3 24 | 12.1% | 17.5% | ||
| Q2 24 | 7.0% | 8.2% | ||
| Q1 24 | 4.4% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDI
| Products | $55.7M | 96% |
| Services | $2.3M | 4% |
RXRX
暂无分部数据
